For patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and diabetes, glucagon-like peptide 1 ...

A Cleveland Clinic study identified key factors that can impact the long-term weight loss of patients with obesity who were ...

A new study finds that weight loss drugs Like Ozempic could trigger bone loss. Doctors explain why, and how to protect ...

A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are ...

The new Lemme GLP-1 Daily Capsules are being called an "Ozempic alternative." But do they really work — and if so, at what ...

Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...

Some people lose more weight on drugs like Ozempic, Wegovy and Saxenda than others, and a new study reveals why that might be.

Amycretin, a dual pathway, oral weight loss drug, was found to be safe and tolerable in a phase 1 study and led to weight loss of up to 13% in people with overweight and obesity.

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

Eli Lilly and Company ’s LLY stock has risen 21.1% in six months compared with an increase of 10.5% for the industry. The ...

UNSW medical researchers say more Australians with type 2 diabetes need to be offered add-on medications that would better ...

A new study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes or ...